Detalles de la búsqueda
1.
Impact of personalized diabetes care on distress and treatment satisfaction in people with breast cancer.
Diabet Med
; 41(4): e15292, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291604
2.
Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Oncologist
; 24(7): e441-e449, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30518616
3.
Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 26(12): 3846-3855, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31222687
4.
Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery.
Breast Cancer Res Treat
; 167(3): 751-759, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29079937
5.
Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ.
J Natl Compr Canc Netw
; 16(4): 387-394, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29632058
6.
Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers.
Breast Cancer Res Treat
; 155(3): 569-78, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26868124
7.
Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.
Cancer
; 121(12): 1937-48, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25757412
8.
Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.
Ann Surg Oncol
; 21(12): 3766-73, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24859938
9.
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer.
Eur J Cancer
; 201: 113920, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38368741
10.
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial.
Nat Commun
; 15(1): 2446, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503755
11.
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.
NPJ Breast Cancer
; 10(1): 42, 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38851818
12.
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer.
NPJ Breast Cancer
; 10(1): 2, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38167908
13.
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer.
J Clin Oncol
; : JCO2301071, 2024 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38190580
14.
Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network.
Cancer
; 119(4): 839-46, 2013 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23011924
15.
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
Nat Commun
; 14(1): 7496, 2023 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980405
16.
Liquid biopsy epigenomic profiling for cancer subtyping.
Nat Med
; 29(11): 2737-2741, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865722
17.
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.
Breast Cancer Res
; 14(5): R129, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23025714
18.
Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
Cancer
; 118(24): 6022-30, 2012 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22674478
19.
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.
Cancer
; 118(22): 5463-72, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22544643
20.
The effect of age on delay in diagnosis and stage of breast cancer.
Oncologist
; 17(6): 775-82, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22554997